References
- Garland CF , GarlandFC. Do sunlight and vitamin D reduce the likelihood of colon cancer?Int. J. Epidemiol.9(3), 227–231 (1980).
- Ma Y , ZhangP, WangF, YangJ, LiuZ, QinH. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J. Clin. Oncol.29(28), 3775–3782 (2011).
- Platz EA , HankinsonSE, HollisBWet al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol. Biomarkers Prev.9(10), 1059–1065 (2000).
- Levine AJ , HarperJM, ErvinCMet al. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr. Cancer39(1), 35–41 (2001).
- Miller EA , KekuTO, SatiaJA, MartinCF, GalankoJA, SandlerRS. Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer109(3), 510–517 (2007).
- Wactawski-Wende J , KotchenJM, AndersonGLet al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med.354(7), 684–696 (2006); Erratum in: N. Engl. J. Med. 354(10), 1102 (2006).
- Fakih M , SungaA. Prevention of colorectal cancer: an emerging role for high-dose vitamin D supplementation?Oncology (Williston Park)20(13), 1707–1710 (2006).
- Murillo G , MatusiakD, BenyaRV, MehtaRG. Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer. J. Steroid Biochem. Mol. Biol.103(3–5), 763–767 (2007).
- Cross HS , BajnaE, BisesGet al. Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res.16(4B), 2333–2337 (1996).
- Matusiak D , MurilloG, CarrollRE, MehtaRG, BenyaRV. Expression of vitamin D receptor and 25-hydroxyvitamin D3–1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol. Biomarkers Prev.14(10), 2370–2376 (2005).
- Kallay E , BareisP, BajnaEet al. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem. Toxicol.40(8), 1191–1196 (2002).
- Bises G , KállayE, WeilandTet al. 25-hydroxyvitamin D3–1alpha-hydroxylase expression in normal and malignant human colon. J. Histochem. Cytochem.52(7), 985–989 (2004).
- Huerta S , IrwinRW, HeberDet al. 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res.62(3), 741–746 (2002).
- Ng K , MeyerhardtJA, WuKet al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J. Clin. Oncol.26(18), 2984–2991 (2008).
- Ng K , VenookAP, SatoKet al. Vitamin D status and survival of metastatic colorectal cancer patients: results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol.33(Suppl. 3), Abstract 507 (2015).
- Fakih MG , TrumpDL, JohnsonCS, TianL, MuindiJ, SungaAY. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int. J. Colorectal Dis.24(2), 219–224 (2009).
- Fakih MG , AndrewsC, McMahonJ, MuindiJR. A prospective clinical trial of cholecalciferol 2000 IU/day in colorectal cancer patients: evidence of a chemotherapy-response interaction. Anticancer Res.32(4), 1333–1338 (2012).
- Reid D , TooleBJ, KnoxSet al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am. J. Clin. Nutr.93(5), 1006–1011 (2011).
- Baker JF , BakerDG, ToedterG, ShultsJ, Von FeldtJM, LeonardMB. Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin. Exp. Rheumatol.30(5), 658–664 (2012).
- Belluco C , NittiD, FrantzMet al. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann. Surg. Oncol.7(2), 133–138 (2000).
- Park JH , WattDG, RoxburghCS, HorganPG, McMillanDC. Colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host. Ann. Surg. doi:10.1097/SLA.0000000000001122 (2015) ( Epub ahead of print).